Brief: Egetis Q1 Loss SEK 74.9 Mln

Egetis Therapeutics AB (publ)

26/04/2023 06:09

April 26 (Reuters) - Egetis Therapeutics AB (publ)
 EGTX.ST :
    * INTERIM REPORT JANUARY-MARCH 2023
    * Q1 NET REVENUE MSEK 6,8 (7,1)
    * Q1 LOSS MSEK -74,9 (-28,8)

Source text for Eikon:  ID:nMFN43Hnbq 
Further company coverage:  EGTX.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))